The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

By Chi D.S.   Venkatraman E.S.   Masson V.   Hoskins W.J.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

Preoperative Value of CA 125 as a Reflection of Tumor Grade in Epithelial Ovarian Cancer

By But I.   Gorisek B.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 166-172

Academic Press

Access to resources Recommend Favorite

Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

By Saygili U.   Guclu S.   Uslu T.   Erten O.   Demir N.   Onvural A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 57-61

Academic Press

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A.   Nielsen D.   Engelholm S.A.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T.   Marth C.   Kaern J.   Nustad K.   Kristensen G.B.   Trope C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite